Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.

× No keyword cloud information.

45 in total

Review 1. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Authors: Javed Butler; Milton Packer; Stephen J Greene; Mona Fiuzat; Stefan D Anker; Kevin J Anstrom; Peter E Carson; Lauren B Cooper; Gregg C Fonarow; Adrian F Hernandez; James L Januzzi; Mariell Jessup; Rita R Kalyani; Sanjay Kaul; Mikhail Kosiborod; JoAnn Lindenfeld; Darren K McGuire; Marc S Sabatine; Scott D Solomon; John R Teerlink; Muthiah Vaduganathan; Clyde W Yancy; Norman Stockbridge; Christopher M O'Connor
Journal: Circulation Date: 2019-12-16 Impact factor: 29.690

2. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors: John B Buse; Deborah J Wexler; Apostolos Tsapas; Peter Rossing; Geltrude Mingrone; Chantal Mathieu; David A D'Alessio; Melanie J Davies
Journal: Diabetologia Date: 2020-02 Impact factor: 10.122

Review 3. Basic Mechanisms of Diabetic Heart Disease.

Authors: Rebecca H Ritchie; E Dale Abel
Journal: Circ Res Date: 2020-05-21 Impact factor: 17.367

4. Role of sodium glucose co-transporter 2 inhibitors in patients with heart failure: an elusive mechanism.

Authors: Hafiz Imran; William Nester; Islam Y Elgendy; Marwan Saad
Journal: Ann Med Date: 2020-05-22 Impact factor: 4.709

Review 5. Promising roles of sodium-glucose cotransporter 2 inhibitors in heart failure prevention and treatment.

Authors: Atsushi Tanaka; Koichi Node
Journal: Diabetol Int Date: 2020-06-11

Review 6. Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Authors: Jiahua Li; Oltjon Albajrami; Min Zhuo; Chelsea E Hawley; Julie M Paik
Journal: Clin J Am Soc Nephrol Date: 2020-06-09 Impact factor: 8.237

Review 7. From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.

Authors: Walter J Paulus; Michael R Zile
Journal: Circ Res Date: 2021-05-13 Impact factor: 17.367

Review 8. SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms.

Authors: Maja Nikolic; Vladimir Zivkovic; Jovana Joksimovic Jovic; Jasmina Sretenovic; Goran Davidovic; Stefan Simovic; Danijela Djokovic; Nemanja Muric; Sergey Bolevich; Vladimir Jakovljevic
Journal: Heart Fail Rev Date: 2021-02-03 Impact factor: 4.214

9. De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study.

Authors: Luis M Pérez-Belmonte; Michele Ricci; Jaime Sanz-Cánovas; Lidia Cobos-Palacios; María D López-Carmona; M Isabel Ruiz-Moreno; Mercedes Millán-Gómez; M Rosa Bernal-López; Sergio Jansen-Chaparro; Ricardo Gómez-Huelgas
Journal: J Clin Med Date: 2021-05-08 Impact factor: 4.241

Review 10. The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities.

Authors: Petra Grubić Rotkvić; Zrinka Planinić; Ana-Marija Liberati Pršo; Jozica Šikić; Edvard Galić; Luka Rotkvić
Journal: Int J Mol Sci Date: 2021-06-01 Impact factor: 5.923